SK62293A3 - Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives - Google Patents

Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives Download PDF

Info

Publication number
SK62293A3
SK62293A3 SK622-93A SK62293A SK62293A3 SK 62293 A3 SK62293 A3 SK 62293A3 SK 62293 A SK62293 A SK 62293A SK 62293 A3 SK62293 A3 SK 62293A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
straight
phenyl
formula
Prior art date
Application number
SK622-93A
Other languages
English (en)
Slovak (sk)
Inventor
Klaus-Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Burkhard Fugmann
Romanis Fruchtmann
Armin Hatzelmann
Muller-Peddinghaus
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK62293A3 publication Critical patent/SK62293A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK622-93A 1992-06-17 1993-06-16 Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives SK62293A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219765A DE4219765A1 (de) 1992-06-17 1992-06-17 Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate

Publications (1)

Publication Number Publication Date
SK62293A3 true SK62293A3 (en) 1994-02-02

Family

ID=6461172

Family Applications (1)

Application Number Title Priority Date Filing Date
SK622-93A SK62293A3 (en) 1992-06-17 1993-06-16 Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives

Country Status (14)

Country Link
EP (1) EP0574774A1 (cs)
JP (1) JPH0665214A (cs)
KR (1) KR940000436A (cs)
CN (1) CN1084166A (cs)
AU (1) AU3981793A (cs)
CA (1) CA2098366A1 (cs)
CZ (1) CZ109593A3 (cs)
DE (1) DE4219765A1 (cs)
FI (1) FI932743A (cs)
HU (1) HU9301754D0 (cs)
IL (1) IL106011A0 (cs)
NO (1) NO932031L (cs)
SK (1) SK62293A3 (cs)
ZA (1) ZA934264B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238307B (it) * 1989-12-22 1993-07-12 Testata per motori alternativi endotermici munita di almeno una valvola comandata sia per aspirazione sia per scarico.
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
JP6557588B2 (ja) 2015-12-04 2019-08-07 株式会社日立ハイテクノロジーズ ドライエッチング方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594425A (en) * 1984-02-09 1986-06-10 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US4675405A (en) * 1984-09-21 1987-06-23 American Home Products Corporation Quinoline compounds as antiallergic and antithrombotic agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
IE66512B1 (en) * 1989-02-28 1996-01-10 Ici Plc Heterocyclic ethers as 5-lipoxygenase inhibitors
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4128681A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Also Published As

Publication number Publication date
IL106011A0 (en) 1993-10-20
ZA934264B (en) 1994-01-14
HU9301754D0 (en) 1993-09-28
CN1084166A (zh) 1994-03-23
JPH0665214A (ja) 1994-03-08
FI932743A0 (fi) 1993-06-15
CA2098366A1 (en) 1993-12-18
CZ109593A3 (en) 1994-01-19
EP0574774A1 (de) 1993-12-22
NO932031D0 (no) 1993-06-03
NO932031L (no) 1993-12-20
KR940000436A (ko) 1994-01-17
FI932743A (fi) 1993-12-18
AU3981793A (en) 1993-12-23
DE4219765A1 (de) 1993-12-23

Similar Documents

Publication Publication Date Title
KR100837420B1 (ko) 5-히드록시-인돌-3-카르복시산에스테르 유도체 및 이의용도
US6043284A (en) Anti-atherosclerotic diaryl compounds
KR100202463B1 (ko) 아미노코우마란 유도체, 그들의 제조방법 및 용도
JP2005533034A5 (cs)
EP0551662A1 (en) Benzofuranyl- and thiophenylmethylthio-alcanecarboxylic acid derivatives
HU208960B (en) Process for producing disubstituted (quinolin-2-yl-methoxy)-phenylacetic acid derivatives
JPH0592957A (ja) ２−置換キノリン類、それらの製造方法、並びに薬剤におけるそれらの使用
US5283252A (en) Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives
WO2001030764A1 (fr) Alcools de phenyl-1-(1h-imidazol-4-yl) substitues en position 1, procede de preparation et utilisation de ces derniers
SK62293A3 (en) Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives
KR20120007566A (ko) 기질 금속단백분해효소 억제제
CZ263992A3 (en) Substituted mandelic acid derivatives, process of their preparation and their use in medicaments
HUT65660A (en) Process for preparing quinolyl-methoxy-phenyl-acetamide derivatives substituted with heterocycles and pharmaceutical compositions containing them
JPH0536436B2 (cs)
SK86593A3 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
CZ390392A3 (en) Benzofuranyl- and thiophenylmethylthio alkanecarboxylic acid derivatives, process of their preparation and use
CA2980221C (en) Indole analogs as 5-oxo-ete receptor antagonists and method of use thereof
JP2002212179A (ja) 新規アニリド誘導体又はその塩及びこれを含有する医薬
US4757078A (en) Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents
JPH08503195A (ja) タルトロン酸類、それらのアセタリックエーテル類及びｏ−エステル類
CZ233692A3 (en) Quinolin-2-yl-methoxybenzyl hydroxyureas
HU187675B (en) Process for preparing new indole derivatives and pharmaceutical compositions containing such compounds
KR800001133B1 (ko) 복소환 치환기를 가진 5-설파모일벤조산 유도체의 제조방법
HUT70171A (en) Novel isobutyl substituted amides of methanesulfonyl-quinolymethoxypnenyl-cycloalkylacetic acid, pharmaceutical compositions comprising them and process for producing thereof
CZ355992A3 (en) Acyl amides and ureas of quinolylmethoxyphenylacetic acid